Hitachi Healthcare Americas Unveils the Latest in Cardiovascular Ultrasound and Reporting at ASE 2018

Twinsburg, OH, June 15, 2018 — Hitachi Healthcare Americas will be demonstrating its latest technologies at ASE 2018 in Nashville, TN June 23rd - 25th. Committed to delivering solutions that help providers meet new challenges, Hitachi’s bed-to-the-report workflow sets a new standard for integrated solutions. 

The Lisendo 880, Hitachi’s premium 2D/3D diagnostic ultrasound solution delivers high quality imaging for your cardiovascular patients in any clinical setting. A true one-system solution for adult, fetal, pediatric and congenital patients, Lisendo 880 boasts HDAnalytics advanced analysis, HemoDynamic Structural Intelligence, an AI fueled automation workflow, and clinical reporting analytics. Lisendo 880 redefines the vision for cardiovascular ultrasound. 

Integrated with the Lisendo 880 is VidiStar, Hitachi’s cloud-based cardiac image management and analytics platform enabling physicians to create value-based reports. As clients move towards value-based care, VidiStar can help them navigate the transition successfully: 

  • with cloud-based solutions, that efficiently deploy and adopt technology across complex and diverse organizations.
  • with structured reporting, that standardizes and improves the quality of clinical reports and streamlines communication, reducing errors and turn-around time.
  • with advanced analytics and data mining, that identifies key value drivers and improves decision making. 

We invite everyone attending ASE to Hitachi’s IMAGINGINSIDERS Science and Technology Theater: 3D Imaging & Diagnostics. Join us for an evening of educational presentations, dinner, drinks and music on Saturday, June 23, at 6:30 p.m. Visit Booth 606 for a demo or to learn more.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.